Recruiting NA Central Venous Catheter

New treatment option for Central Venous Catheter

Official title Central Venous Catheter Placement With Thoracic Ultrasound and Intracavity ECG Positioning

ClinicalTrials.gov ID: NCT07291869

What this study is testing

What it's testing
The goal of this interventional study is to assess the feasibility of two bedside techniques for confirming central venous catheter (CVC) placement and detecting complications: Intracavity ECG monitoring to confirm internal jugular vein CVC tip position. Thoracic point-of-care ultrasound (POCUS) to rule out pneumothorax following CVC insertion.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Adult (aged ≥ 18 years)
  • Admitted, or planned for admission, to critical care
  • Requiring central venous catheter insertion as a part of their usual care
  • Suitable for both right or left internal jugular vein insertion

You likely can't join if

  • Previously assigned by chance into CVC-TIP
  • Atrial fibrillation on 12-lead ECG
  • Cardiovascular instability, defined as
  • Noradrenaline dose \> 0.5mcg/kg/min
  • Rapidly escalating doses of vasopressors / inotropes
  • Difficulty in obtaining thoracic ultrasound images due to either
See the full eligibility criteria
Who can join
  • Adult (aged ≥ 18 years)
  • Admitted, or planned for admission, to critical care
  • Requiring central venous catheter insertion as a part of their usual care
  • Suitable for both right or left internal jugular vein insertion
What rules you out
  • Previously assigned by chance into CVC-TIP
  • Atrial fibrillation on 12-lead ECG
  • Cardiovascular instability, defined as
  • Noradrenaline dose \> 0.5mcg/kg/min
  • Rapidly escalating doses of vasopressors / inotropes
  • Difficulty in obtaining thoracic ultrasound images due to either
  • Weight \> 120kg
  • Existing pneumothorax (either side)
  • Subcutaneous emphysema
  • Wounds / dressing over anterior chest wall
  • Existing pacemaker
  • Non-English speaking participants
  • Death perceived as imminent
  • Any other reason as determined by treating clinician

The study team makes the final eligibility decision.

Where it's taking place

  • York, North Yorkshire, United Kingdom

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include York, North Yorkshire, United Kingdom. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.